|
| Press Releases |
|
 |
|
| Wednesday, June 30, 2021 |
|
|
医思健康公布2020/21年度全年业绩 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）公布截至2021年3月31日止财政年度（「年内」）之全年业绩。 more info >> |
|
|
EC Healthcare Announces FY2020/21 Annual Results |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces today its annual results for the fiscal year ended 31 March 2021 (the "Year"). more info >> |
|
| Tuesday, June 15, 2021 |
|
|
医思健康收购宠物相关业务 发挥客户业务协同性 整合及企业化宠物市场 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布进入宠物市场赛道，集团以现金总代价6,600万港元向张兽医及陈兽医收购亨润、溢丰、香港兽医影像中心及锋冠 (「该等目标公司」）51%股权。 more info >> |
|
|
醫思健康收購寵物相關業務 發揮客戶業務協同性 整合及企業化寵物市場 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈進入寵物市場賽道，集團以現金總代價6,600萬港元向張獸醫及陳獸醫收購亨潤、溢豐、香港獸醫影像中心及鋒冠 (「該等目標公司」）51%股權。 more info >> |
|
|
EC Healthcare Acquires Pet Industry Business, Allowing Clientele and Business Synergies, To Consolidate and Corporatize Pet Industry |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group enters the pet industry and will acquire 51% equity interests in King Equity more info >> |
|
| Friday, June 11, 2021 |
|
|
医思健康与康哲药业签署战略合作备忘录 发挥医美上下游协同效应 共同促进行业之医学产品及人才发展 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）与康哲药业控股有限公司（「康哲药业」；香港联交所股份编号：867）联合宣布，集团与康哲药业附属公司订立战略合作备忘录 more info >> |
|
|
醫思健康與康哲藥業簽署戰略合作備忘錄 發揮醫美上下游協同效應 共同促進行業之醫學產品及人才發展 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）與康哲藥業控股有限公司（「康哲藥業」；香港聯交所股份編號：867）聯合宣佈，集團與康哲藥業附屬公司訂立戰略合作備忘錄 more info >> |
|
|
Strategic Collaboration Memorandum between EC Healthcare and China Medical System Utilizes the Synergy of Upstream and Downstream of the Aesthetic Medical Industry, Promotes the Development of Medical Products and Talents |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* and China Medical System Holdings Limited (the "CMS", SEHK stock code: 867), jointly announce that the Group and a subsidiary of the CMS entered into a memorandum in relation to the strategiccollaboration more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
珠宝双展匯聚逾82,000环球买家
Mar 9, 2025 13:51 HKT/SGT
|
|
|
珠寶雙展匯聚逾82,000環球買家
Mar 9, 2025 13:41 HKT/SGT
|
|
|
Twin jewellery shows attract over 82,000 global buyers
Mar 9, 2025 13:19 HKT/SGT
|
|
|
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million
Mar 8, 2025 19:40 HKT/SGT
|
|
|
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation
Mar 8, 2025 19:20 HKT/SGT
|
|
|
uSMART Securities Initiates Coverage on NAAS Technology with a 'Buy' Rating and a Target Price of US$3.2 per ADS, Citing Industry Leadership and Profitability Outlook
Mar 7, 2025 21:26: JST
|
|
|
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation
Mar 7, 2025 20:31: JST
|
|
|
uSMART Securities Initiates Coverage on NAAS Technology with a 'Buy' Rating and a Target Price of US$3.2 per ADS, Citing Industry Leadership and Profitability Outlook
Mar 7, 2025 20:26 HKT/SGT
|
|
|
雲頂新耀股價創3年新高 AI+mRNA賦能管線重塑估值
Mar 7, 2025 19:24 HKT/SGT
|
|
|
云顶新耀股价创3年新高 AI+mRNA赋能管线重塑估值
Mar 7, 2025 19:16 HKT/SGT
|
|
|
業聚醫療連續四年實現收入增長 達1.64億美元創新高 純利達3,970萬美元 建議派發末期股息每股10港仙
Mar 7, 2025 18:28 HKT/SGT
|
|
|
业聚医疗连续四年实现收入增长 达1.64亿美元创新高 纯利达3,970万美元 建议派发末期股息每股10港仙
Mar 7, 2025 18:10 HKT/SGT
|
|
|
東信營銷科技：中國AI營銷龍頭斬獲多模態雙備案 技術實力獲國家級認證
Mar 7, 2025 17:58 HKT/SGT
|
|
|
东信营销科技：中国AI营销龙头斩获多模态双备案 技术实力获国家级认证
Mar 7, 2025 17:20 HKT/SGT
|
|
|
Japan's Telecommunications Carriers Enhance Disaster Response with On-site Training for Joint Use of Marine Vessels
Mar 7, 2025 16:24 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
